"10.1371_journal.pone.0047662","plos one","2012-10-15T00:00:00Z","John Gatfield; Celia Mueller Grandjean; Thomas Sasse; Martine Clozel; Oliver Nayler","Actelion Pharmaceuticals Ltd., Allschwil, Switzerland","Conceived and designed the experiments: JG. Performed the experiments: CMG TS. Analyzed the data: CMG TS JG. Wrote the paper: JG ON MC.","All authors are employees of Actelion Pharmaceuticals Ltd. Bosentan is a marketed product of Actelion Pharmaceuticals Ltd., macitentan is a product in development by Actelion Pharmaceuticals, and both compounds are under protection by patents licensed in or held by Actelion Pharmaceuticals Ltd. (bosentan: patent family corresponding to EP 526708 (F. Hoffmann-La Roche AG); macitentan: patent family corresponding to WO 02/053557 (Actelion Pharmaceuticals Ltd)). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","10","John Gatfield","JG",5,TRUE,1,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
